CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
IMPACT-AML focuses on improving treatment options for patients with relapsed or refractory acute myeloid leukemia by comparing high-intensity chemotherapy with biology-driven low-intensity alternatives. The project aims to gather real-world data to inform healthcare providers about effective and affordable treatment st…
In IMPACT-AML, a multidisciplinar R/R AML represents a model of high-impact disease, in which no standard of care exists, and where we have an urgent need for new evidence on possible therapies;
AML offers the setting in which methodological innovation will combine powerful instruments of clinical trials with personalized medicine through academic efforts.
Hereby, we propose to create an inclusive master framework for relapsed or refractory acute myeloid leukemia (STREAM) to include patients wit…
ISTITUTO ROMAGNOLO PER LO STUDIO DEI TUMORI DINO AMADORI - IRST SRL
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
THE CYPRUS FOUNDATION FOR MUSCULAR DYSTROPHY RESEARCH CYRUS INSTIT OF NEURO & GENETICS
Cyprus, AGIOS DOMETIOS
Type: University / higher education
Activity type: Higher or Secondary Education Establishments
SME: No
FONDAZIONE G.I.M.EM.A. - FRANCO MANDELLI ONLUS
Italy, Roma
Type: Research institute
Activity type: Research Organisations
SME: No
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
Guests see up to 5 sectors.
Guests see up to 5 keywords.
